Detalhe da pesquisa
1.
Combination of Type I and Type II MET Tyrosine Kinase Inhibitors as Therapeutic Approach to Prevent Resistance.
Mol Cancer Ther
; 21(2): 322-335, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34789563
2.
EGFR Inhibition Enhances the Cellular Uptake and Antitumor-Activity of the HER3 Antibody-Drug Conjugate HER3-DXd.
Cancer Res
; 82(1): 130-141, 2022 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34548332
3.
Dynamic single-cell RNA sequencing identifies immunotherapy persister cells following PD-1 blockade.
J Clin Invest
; 131(2)2021 01 19.
Artigo
Inglês
| MEDLINE | ID: mdl-33151910
4.
Intrinsic Immunogenicity of Small Cell Lung Carcinoma Revealed by Its Cellular Plasticity.
Cancer Discov
; 11(8): 1952-1969, 2021 08.
Artigo
Inglês
| MEDLINE | ID: mdl-33707236
5.
A High-Throughput Immune-Oncology Screen Identifies EGFR Inhibitors as Potent Enhancers of Antigen-Specific Cytotoxic T-lymphocyte Tumor Cell Killing.
Cancer Immunol Res
; 6(12): 1511-1523, 2018 12.
Artigo
Inglês
| MEDLINE | ID: mdl-30242021
6.
Quantification of metastatic load in a syngeneic murine model of metastasis.
Cancer Lett
; 405: 56-62, 2017 10 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28729049